Esperion to Report Second Quarter 2022 Financial Results August 2, 2022
July 12 2022 - 8:00AM
Esperion (NASDAQ: ESPR), today announced it will report second
quarter 2022 financial results before the open of the U.S.
financial markets on Tuesday, August 2, 2022.
Following the release, company management will host a webcast at
8:00 a.m. ET to discuss financial results and business progress.
Please click here to pre-register to participate in the conference
call and obtain your dial in number and PIN. You can also visit the
Esperion website to listen to the call via live webcast. A recorded
version will be available under the same link immediately following
the conclusion of the conference call. Already registered? Access
with your PIN here.
A live audio webcast can be accessed on the investor and media
section of the Esperion website at investor.esperion.com. Access to
the webcast replay will be available approximately two hours after
completion of the call and will be archived on the Company's
website for approximately 90 days.
ESPERION Therapeutics
Esperion works hard to make our medicines easy to get, easy to
take and easy to have. We discover, develop and commercialize
innovative medicines and combinations to lower cholesterol,
especially for patients whose needs aren’t being met by the status
quo. Our entrepreneurial team of industry leaders is inclusive,
passionate and resourceful. We are singularly focused on managing
cholesterol so you can improve your health easily. Esperion
commercializes NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic
acid and ezetimibe) Tablets and is the leader in the development of
convenient oral, once-daily non-statin LDL-cholesterol lowering
drugs for patients with high levels of bad cholesterol. For more
information, please visit www.esperion.com and follow us on Twitter
at www.twitter.com/EsperionInc.
Contact:Corporate
Communicationscorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024